Uwe Weisner

April 12, 2021

As General Manager Corporate Intellectual Property at Volkswagen AG in Wolfsburg, Germany, Uwe is responsible for filing, prosecuting, licensing and enforcing Volkswagen’s Patents, Trademarks, Design Rights, Internet-Domains and defending against third party IP claims. In addition, he is responsible for standardization. Prior, Uwe served more than 15 years as a Patent Manager for Volkswagen AG and Audi AG, also located in Germany. Further functions: Chairman of the IP Committee of VDA (German Association of Automotive Industry), Board Member of the IP Committee of BDI (Association of German Industries) and Board Member of VPP (Association of Industry Patent Professionals in Germany). From 2010 to 2017 Lecturer at the Technical University of Braunschweig for “Business Practice of Intellectual Property.”

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

October 13, 2025
On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

September 9, 2025
By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More

If Private Sector R&D Is the Future, IP Policy Must Catch Up

September 8, 2025
By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely
Read More